To investigate the Correlation between plasma D-Dimer levels and Clinicopathological Characteristics of Cervical Cancer. because Plasma D-Dimer levels were determined using immunoturbidimetry in the three groups of cervical cancer, IN and healthy persons, because and detect the distinction among them. To analyzed the relationship among plasma D-Dimer levels and the invasion, metastasize of cervical cancer further. Plasma D-Dimer levels of the group of cervical cancer had significantly higher than those of CIN and healthy control groups (χ2=13.5436, P﹤0.005;χ2=15.7082, P﹤0.005,respectively),and then plasma D-Dimer levels had not statistically significant differences compared CIN with healthy control group(χ2=0.0016, P>0.05). Plasma D-Dimer levels was positively rank-correlated with tumor diameter, lymph node metastasis, numbers and proportion of metastatic nodes(P<0.05),but no correlation with clinical stage, histological grades, infiltrative depth of muscle, tumor embolus of vessel, latero-uterus infiltration and encroachment of corpus uteri(P>0.05). Plasma D-Dimer levels were much higher in patients with cervical cancer than those of nontumors, which was distinctively associated with tumor diameter, lymphnode metastasis (P<0.05). It is suggested that plasma D-Dimer levels could be play an important role in the invasion and transfer process of cervical cancer.

Lihua Zhang, Yuanyuan Zhao, Li Li and Huadong Xin. Correlation between plasma D-Dimer levels and Clinicopathological Characteristics of Cervical Cancer. International Journal of Public Health and Preventive Medicine (2021), Vol. 2, Issue 4: 1-7. https://doi.org/10.38007/IJPHPM.2021.020401.

[1] Ay C,Dunkler D,Pirker R,et al. High D-dimer levels are associated with poor prognosis in cancer patiengts. Haematologica, 2012, 97(8):1158-1164. 

[2] Qu HL. Correlative study on the plasma fibrinogen,D-dimer between Prognosis in advanced stage of nonsmall-cell lung cancer.Chongqing Medicine,2015,44(19):2665-2667. 

[3] Diao D,Zhu K,Wang Z,et al. Prognostic value of the D-dimer test in esophageal cancer during the perioperative period . J Surg Oncol, 2013,108(1):34-41. 

[4] Zhang PP,Sun JW,Wang XY,et al. Preoperative plasma D-dimer levels predict survival in patients with operable non-small cell lung cancer independently of venous thromboembolism. Eur J Surg Oncol,2013,39(9):951-956.

[5] Gao CH,Gao QS,Peng LH. The study of the changes on the D-dimer and FIB level in Peripheral blood of ovarian cancer patients. Chinese Journal of Immunology,2015,31(4):534-536. 

[6] Jiang WH,Gao J,Liu PF. Relationship of D-dimer with the prognosis of non-Hodgkin′s lymphoma. Chinese Journal of Clinical Oncology,2013,40(14):838-841. 

[7] Yu XJ,Zhang YQ,Zhu PF. Changes of plasma fibrinogen and D-dimer levels before and after cervical cancer surgery. Maternal & Child Health Care of China,2013,28(3):418-420.

[8] Shi H,Wang LQ,Liang Y. Clinical significance of quantification of D-dimer in neoplasms patients.  Chinese Journal of laboratory Diagnosis,2013,17(2):341-342. 

[9] Zhang LH,Xin HD, Wang CL,et al.Clinical Study on Correlation of COX-2 and Prognosis in Cervical Squamous-celled Carcinoma.China Tropical Medicine,2015,15(9):1119-1123. Zhang Lihua, Xin Huadong, Wang Chunli et al. The effect of COX-2 on the prognosis of cervical squamous cell carcinoma . Chinese Tropical Medicine,2015,15(9):1119-1123.

[10] Hu Y,Wu YL,Zou L,et al. Correlation between coagulation function, TAFI levels in tissue and lymph node metastasis in squamous carcinoma of the cervix. Journal of Practical Obstetrics and Gynecology,2013,29(3):202-205. 

[11] Xu J,Qi DL,Li XB,et al. Correlation between plasma  D-dimer levels and clinicopathologic characteristics of esophageal squamous cell carcinoma. Chinese Journal of Clinical Oncology,2014,41(2):105-107.

[12] Hunter LA,Krafft S,Stingo F,et al. High quality machinerobust  image features: Identification in nonsmall cell lung cancer computed tomography images . Med Phys,2013,40(12):916-917.

[13] Der SD,Sykes J,Pintilie M,et al. Validation of a Histology-independent prognostic gene signature for early-stage,non-small-cell lung cancer including stage IA patients . J Thorac Oncol,2013,9(1):59-64.